{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:52:19Z","timestamp":1761749539170,"version":"build-2065373602"},"reference-count":95,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.path.2023.02.001","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T16:41:32Z","timestamp":1683218492000},"page":"233-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Navigating the Heterogeneity of Follicular Lymphoma and its Many Variants"],"prefix":"10.1016","volume":"16","author":[{"suffix":"Jr.","given":"Abner","family":"Louissaint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.path.2023.02.001_bib1","series-title":"WHO classification of Tumours of haematopoietic and lymphoid tissues, revised","first-page":"266","article-title":"Follicular lymphoma","author":"Jaffe","year":"2017"},{"issue":"5","key":"10.1016\/j.path.2023.02.001_bib2","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1200\/JCO.1988.6.5.919","article-title":"Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation","volume":"6","author":"Rowley","year":"1988","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/leu.2015.330","article-title":"Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus","volume":"30","author":"Leich","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.path.2023.02.001_bib5","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1038\/nm.3940","article-title":"Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis","volume":"21","author":"Zhang","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.path.2023.02.001_bib6","doi-asserted-by":"crossref","first-page":"e1002197","DOI":"10.1371\/journal.pmed.1002197","article-title":"Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study","volume":"13","author":"Kridel","year":"2016","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ajh.24701","article-title":"BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab","volume":"92","author":"Huet","year":"2017","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrc.2017.127","article-title":"From genetics to the clinic: a translational perspective on follicular lymphoma","volume":"18","author":"Huet","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.path.2023.02.001_bib9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ccell.2020.03.016","article-title":"Cathepsin S Regulates Antigen Processing and T Cell Activity in Non-Hodgkin Lymphoma","volume":"37","author":"Dheilly","year":"2020","journal-title":"Cancer Cell"},{"issue":"19","key":"10.1016\/j.path.2023.02.001_bib10","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1182\/blood.2020008119","article-title":"Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma","volume":"137","author":"Bolen","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3324\/haematol.2009.013177","article-title":"Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials","volume":"95","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.path.2023.02.001_bib12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1182\/blood-2012-05-429514","article-title":"Pediatric-type nodal follicular lymphoma: an indolent clonal proliferation in children and adults with high proliferation index and no BCL2 rearrangement","volume":"120","author":"Louissaint","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.path.2023.02.001_bib13","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood-2015-12-682591","article-title":"Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations","volume":"128","author":"Louissaint","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib14","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.V99.6.1959","article-title":"Clinicopathologic analysis of follicular lymphoma occurring in children","volume":"99","author":"Lorsbach","year":"2002","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pbc.23152","article-title":"Pediatric indolent lymphoma--would less be better?","volume":"57","author":"Perkins","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1365-2141.2011.08969.x","article-title":"Guidelines on the investigation and management of follicular lymphoma","volume":"156","author":"McNamara","year":"2012","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib17","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s00277-013-1785-2","article-title":"Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a \"Watch and wait\" strategy after complete resection","volume":"92","author":"Attarbaschi","year":"2013","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.path.2023.02.001_bib18","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/bjh.15194","article-title":"Incidence and outcomes of rare paediatric non-hodgkin lymphomas","volume":"184","author":"Sorge","year":"2019","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.path.2023.02.001_bib19","doi-asserted-by":"crossref","first-page":"e28416","DOI":"10.1002\/pbc.28416","article-title":"Rare non-Hodgkin lymphoma of childhood and adolescence: A consensus diagnostic and therapeutic approach to pediatric-type follicular lymphoma, marginal zone lymphoma, and nonanaplastic peripheral T-cell lymphoma","volume":"67","author":"Attarbaschi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib20","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1097\/IOP.0000000000001556","article-title":"Conjunctival Pediatric-Type Follicular Lymphoma","volume":"36","author":"Okudolo","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib21","first-page":"e22023","article-title":"Conjunctival Pediatric-Type Follicular Lymphoma in a Young Male: A Case Report and Literature Review","volume":"14","author":"Alnaim","year":"2022","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.path.2023.02.001_bib22","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1097\/IOP.0000000000001500","article-title":"Conjunctival Pediatric Follicular Lymphoma: Case Report and Literature Review","volume":"36","author":"AlSemari","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"8","key":"10.1016\/j.path.2023.02.001_bib23","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.path.2023.02.001_bib24","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-019-02681-y","article-title":"Novel markers in pediatric-type follicular lymphoma","volume":"475","author":"Agostinelli","year":"2019","journal-title":"Virchows Arch"},{"issue":"1","key":"10.1016\/j.path.2023.02.001_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/gcc.22014","article-title":"High resolution copy number analysis of IRF4 translocation-positive diffuse large B-cell and follicular lymphomas","volume":"52","author":"Salaverria","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.path.2023.02.001_bib28","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/modpathol.2016.102","article-title":"A\u00a0study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"29","author":"Ozawa","year":"2016","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2017-03-776278","article-title":"Mutations of MAP2K1 are frequent in pediatric-type follicular lymphoma and result in ERK pathway activation","volume":"130","author":"Schmidt","year":"2017","journal-title":"Blood"},{"issue":"Suppl","key":"10.1016\/j.path.2023.02.001_bib30","first-page":"S98","article-title":"Pediatric follicular lymphomas, marginal zone lymphomas, and marginal zone hyperplasia","volume":"122","author":"Swerdlow","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00428-015-1855-z","article-title":"Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4\/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia","volume":"468","author":"Quintanilla-Martinez","year":"2016","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAP.0000000000000144","article-title":"Pediatric-type Follicular Lymphoma and Pediatric Nodal Marginal Zone Lymphoma: Recent Clinical, Morphologic, Immunophenotypic, and Genetic Insights","volume":"24","author":"Koo","year":"2017","journal-title":"Adv Anat Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1309\/4EJ8T3R2ERKQ61WH","article-title":"Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations","volume":"121","author":"Kussick","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"issue":"12","key":"10.1016\/j.path.2023.02.001_bib35","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.path.2023.02.001_bib36","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.path.2023.02.001_bib37","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.path.2023.02.001_bib38","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","article-title":"Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases","volume":"67","author":"Santucci","year":"1991","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.path.2023.02.001_bib39","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1200\/JCO.2001.19.16.3602","article-title":"Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study","volume":"19","author":"Grange","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib40","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.pas.0000126775.27698.6e","article-title":"Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas","volume":"28","author":"Vergier","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2023.02.001_bib41","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jaad.2010.06.059","article-title":"Clinicopathologic features of early lesions of primary cutaneous follicle center lymphoma, diffuse type: implications for early diagnosis and treatment","volume":"65","author":"Gulia","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib42","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jaad.2014.01.862","article-title":"Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis","volume":"70","author":"Abdul-Wahab","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib43","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1309\/AJCP4SUBR4NPSPTN","article-title":"Diagnostic and prognostic value of BCL2 rearrangement in 53 patients with follicular lymphoma presenting as primary skin lesions","volume":"143","author":"Pham-Ledard","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.path.2023.02.001_bib44","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib45","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.path.2023.02.001_bib46","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.path.2023.02.001_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.0303-6987.2005.00495.x","article-title":"WHO\/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects","volume":"32","author":"Burg","year":"2005","journal-title":"J\u00a0Cutan Pathol"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib48","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00000478-200106000-00004","article-title":"Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib49","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1200\/JCO.2002.20.3.647","article-title":"Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features","volume":"20","author":"Mirza","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.path.2023.02.001_bib50","first-page":"1167","article-title":"Schizophrenia: etiology and pharmacotherapy","volume":"4","author":"Mohammadi","year":"2001","journal-title":"Idrugs"},{"issue":"12","key":"10.1016\/j.path.2023.02.001_bib51","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1182\/blood.V95.12.3922","article-title":"Primary cutaneous follicle center cell lymphoma with follicular growth pattern","volume":"95","author":"Cerroni","year":"2000","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2133.2001.04128.x","article-title":"Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma","volume":"144","author":"Child","year":"2001","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.path.2023.02.001_bib53","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/modpathol.3880398","article-title":"Cutaneous follicle center lymphoma: a clinicopathologic study of 19 cases","volume":"14","author":"Aguilera","year":"2001","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.path.2023.02.001_bib54","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","article-title":"Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes","volume":"27","author":"Goodlad","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.2005.02.0842","article-title":"Array-based comparative genomic hybridization analysis reveals recurrent chromosomal alterations and prognostic parameters in primary cutaneous large B-cell lymphoma","volume":"24","author":"Dijkman","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.path.2023.02.001_bib56","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.jid.2016.04.018","article-title":"MYD88 Somatic Mutation Is a Diagnostic Criterion in Primary Cutaneous Large B-Cell Lymphoma","volume":"136","author":"Menguy","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib57","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jid.2018.04.038","article-title":"Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type","volume":"138","author":"Zhou","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib58","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","article-title":"Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2023.02.001_bib59","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1111\/j.1349-7006.2011.01980.x","article-title":"Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan","volume":"102","author":"Takata","year":"2011","journal-title":"Cancer Sci"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib60","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1200\/JCO.2010.32.9193","article-title":"Primary follicular lymphoma of the duodenum is a distinct mucosal\/submucosal variant of follicular lymphoma: a retrospective study of 63 cases","volume":"29","author":"Schmatz","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.path.2023.02.001_bib61","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1182\/blood-2018-03-837252","article-title":"Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles","volume":"132","author":"Hellmuth","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib62","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/PAS.0b013e31818e6489","article-title":"Low stage follicular lymphoma: biologic and clinical characterization according to nodal or extranodal primary origin","volume":"33","author":"Weinberg","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"45","key":"10.1016\/j.path.2023.02.001_bib63","doi-asserted-by":"crossref","first-page":"78410","DOI":"10.18632\/oncotarget.19240","article-title":"Sites of extranodal involvement are prognostic in patients with stage 1 follicular lymphoma","volume":"8","author":"Shastri","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib64","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.clml.2019.02.011","article-title":"Early Stage Extranodal Follicular Lymphoma: Characteristics, Management, and Outcomes","volume":"19","author":"Andraos","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"9","key":"10.1016\/j.path.2023.02.001_bib65","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jcp.55.9.684","article-title":"Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics","volume":"55","author":"Pileri","year":"2002","journal-title":"J\u00a0Clin Pathol"},{"issue":"7","key":"10.1016\/j.path.2023.02.001_bib66","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/PAS.0b013e31802ee4ab","article-title":"Primary follicular lymphoma of the testis and epididymis in adults","volume":"31","author":"Bacon","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.path.2023.02.001_bib67","first-page":"225","article-title":"Follicular large cell lymphoma localized to the testis in children","volume":"168","author":"Pakzad","year":"2002","journal-title":"J\u00a0Urol"},{"issue":"7","key":"10.1016\/j.path.2023.02.001_bib68","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/(SICI)1097-0142(19990401)85:7<1626::AID-CNCR27>3.0.CO;2-0","article-title":"Primary follicular lymphoma of the testis in childhood","volume":"85","author":"Finn","year":"1999","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib69","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/his.14378","article-title":"Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma","volume":"79","author":"Hamamoto","year":"2021","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.path.2023.02.001_bib70","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/PAS.0b013e31817d7470","article-title":"Follicular lymphoma of the thyroid gland","volume":"33","author":"Bacon","year":"2009","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib71","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/PAS.0b013e31822bd8a8","article-title":"Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups","volume":"35","author":"Ozsan","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib72","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/PAS.0000000000002003","article-title":"Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL)","volume":"47","author":"Saksena","year":"2023","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.path.2023.02.001_bib73","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.humpath.2013.02.004","article-title":"The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-\"negative\" grade 1\/2 follicular lymphomas","volume":"44","author":"Adam","year":"2013","journal-title":"Hum Pathol"},{"issue":"22","key":"10.1016\/j.path.2023.02.001_bib74","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.path.2023.02.001_bib75","doi-asserted-by":"crossref","first-page":"5482","DOI":"10.1182\/bloodadvances.2022008355","article-title":"Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III\/IV","volume":"6","author":"Los-de Vries","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib76","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1309\/AJCPTMA1F6LWYTQV","article-title":"Software-automated counting of Ki-67 proliferation index correlates with pathologic grade and disease progression of follicular lymphomas","volume":"140","author":"Samols","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib77","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.pas.0000172191.87176.3b","article-title":"Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features","volume":"29","author":"Wang","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2023.02.001_bib78","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/PAS.0000000000001609","article-title":"Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy","volume":"45","author":"Sohani","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood.V68.4.837.837","article-title":"What should be the morphologic criteria for the subdivision of follicular lymphomas?","volume":"68","author":"Nathwani","year":"1986","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.path.2023.02.001_bib80","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hon.2900010209","article-title":"Criteria for the cytologic subclassification of follicular lymphomas: a proposed alternative method","volume":"1","author":"Mann","year":"1983","journal-title":"Hematol Oncol"},{"issue":"10","key":"10.1016\/j.path.2023.02.001_bib81","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/PAS.0000000000001726","article-title":"High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B","volume":"45","author":"Laurent","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.path.2023.02.001_bib82","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.humpath.2017.11.002","article-title":"Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma","volume":"72","author":"El Behery","year":"2018","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.path.2023.02.001_bib83","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.3324\/haematol.2017.175059","article-title":"Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort","volume":"103","author":"Rimsza","year":"2018","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.path.2023.02.001_bib84","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/ajcp\/aqz008","article-title":"Stratification of Follicular Lymphoma: Time for a Paradigm Shift?","volume":"151","author":"Kroft","year":"2019","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.path.2023.02.001_bib85","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","article-title":"Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL","volume":"27","author":"Koch","year":"2016","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.path.2023.02.001_bib86","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.3324\/haematol.2017.181024","article-title":"Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2","volume":"103","author":"Horn","year":"2018","journal-title":"Haematologica"},{"issue":"14","key":"10.1016\/j.path.2023.02.001_bib87","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa1614598","article-title":"Obinutuzumab for the First-Line Treatment of Follicular Lymphoma","volume":"377","author":"Marcus","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.path.2023.02.001_bib88","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2017.76.8960","article-title":"Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety","volume":"36","author":"Hiddemann","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"10.1016\/j.path.2023.02.001_bib89","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJMoa1805104","article-title":"Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma","volume":"379","author":"Morschhauser","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.path.2023.02.001_bib90","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1200\/JCO.19.01073","article-title":"Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study","volume":"37","author":"Bachy","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.path.2023.02.001_bib91","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.2019000258","article-title":"Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma","volume":"134","author":"Freeman","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib92","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1182\/blood.2020010263","article-title":"Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials","volume":"139","author":"Casulo","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.path.2023.02.001_bib93","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.path.2023.02.001_bib94","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.path.2023.02.001_bib95","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-07-168682","article-title":"A\u00a0distinctive subtype of t(14;18)-negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36","volume":"113","author":"Katzenberger","year":"2009","journal-title":"Blood"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875918123000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T14:44:11Z","timestamp":1761749051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875918123000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":95,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1875918123000144"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2023.02.001","relation":{},"ISSN":["1875-9181"],"issn-type":[{"type":"print","value":"1875-9181"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating the Heterogeneity of Follicular Lymphoma and its Many Variants","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2023.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}